Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis

Explore clinical trials studying Liver Cirrhosis. Study availability and eligibility vary by location and protocol.

163 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis trial results

Completed

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

NCT01865812

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
View Trial Details
Completed

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

NCT03602560

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Institute for Liver Health Chandler, Arizona, United States
  • Mayo Clinic Arizona - PPDS Phoenix, Arizona, United States
  • The Institute for Liver Health-Tucson Tucson, Arizona, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 156 locations
View Trial Details
Completed

Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

NCT02955602

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Institute for Liver Health Chandler, Arizona, United States
  • Southern California Research Center Coronado, California, United States
  • Standford University Medicine Palo Alto, California, United States
  • University of California, Davis Medical Center Sacramento, California, United States
View all 38 locations
View Trial Details
Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

NCT03226067

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University California Davis Sacramento, California, United States
  • Ventura Clinical Trials Ventura, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 61 locations
View Trial Details
Completed

Pegfilgrastim in Patients With Alcoholic Hepatitis

NCT02776059

Conditions
Alcohol-Induced Disorders, Alcohol-Related Disorders, Alcoholic Hepatitis, +12 more
Locations
  • VA Loma Linda Healthcare System Loma Linda, California, United States
  • VA Long Beach Healthcare System Long Beach, California, United States
  • LAC-USC Medical Center Los Angeles, California, United States
  • Harbor-UCLA Medical Center Torrance, California, United States
View Trial Details
Completed

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

NCT00570765

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +8 more
Locations
  • Henry Ford Detroit, Michigan, United States
  • Baylor College of Medicine Houston, Texas, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
  • Virginia Mason Medical Center Seattle, Washington, United States
View all 21 locations
View Trial Details

Related conditions